Life Sciences Advanced Technologies, Inc was founded 40 years ago and the first company in the world which manufacture AMV RT. AMV RT is later used in NASBA, RT-PCR, LAMP, for research and development of many infecious diseases worldwide, such as HIV, HPV, Hepatitis, Pneumonia, Dengue virus, Zika virus, common flu virus etc.
As a world leader of reagents for research and development of infectious diseases, we are proud of our NASBA enzyme. On this page, we selected a list of scientific publications in top international journals by our top scientists or scientists who bought our AMV RT enzymes and NASBA acusphere for their research and development:
LSAT booth in BioFlorida 2016
General Manager of Life Sciences Advanced Technologies Inc, Fred Perez, Chief Technologies Officer, Dr. Zhan Zhang, briefed Congressman Ted Yoho about the edge Life Sciences Advanced Technologies Inc. has on research and development of infectious diseases.